Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BIOS Capital Management, LP | 6.00M | $4.0M | 6.71% | -- | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.00M | $2.0M | 3.36% | -- | 2026-03-31 |
| DAVENPORT & Co LLC | 2.89M | $2.0M | 3.24% | +21.0K | 2026-03-31 |
| RENAISSANCE TECHNOLOGIES LLC | 1.12M | -- | 1.25% | +147.6K | 2026-03-31 |
| BlackRock, Inc. | 968.4K | -- | 1.08% | -46.0K | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 920.2K | -- | 1.03% | +46.3K | 2026-03-31 |
| Hilton Capital Management, LLC | 549.0K | -- | 0.61% | -- | 2026-03-31 |
| VANGUARD FIDUCIARY TRUST CO | 463.7K | -- | 0.52% | -- | 2026-03-31 |
| Dauntless Investment Group, LLC | 431.0K | -- | 0.48% | -- | 2026-03-31 |
| CM Management, LLC | 400.0K | -- | 0.45% | +200.0K | 2026-03-31 |
